MedBioSphere
Articles Videos The Web  
    

lion New Technology Expands Market

Selected Abstract

Edwards Lifesciences to Acquire Percutaneous Valve Technologies, Inc. for $125 Million; New Technology Expands Market With Interventional Alternative for Patients With Heart Valve Disease.
Edwards Lifesciences Corporation , a global leader in medical technologies to treat advanced cardiovascular disease, and the world's number-one heart valve company, announced today that it has entered into a definitive agreement to acquire Percutaneous Valve Technologies, Inc. (PVT), a privately ...
December 15, 2003; PR Newswire

Read the full article with a free-trial membership at HighBeam Research



Related Articles

No Results Found.